Reaction
Health Assessment Questionnaire Score Increased reporting signals
As of the last recalculation, Health Assessment Questionnaire Score Increased appears in 100 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is CERTOLIZUMAB PEGOL (PRR 156.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Certolizumab Pegol | 47 | 156.6 | 156.7 |
| Bimekizumab | 6 | 62.3 | 62.3 |